Home / Filing-delay notices (10-Q) / KALA BIO, Inc.
Filed 2025-11-14 路 Form NT 10-Q 路 Accession 0001104659-25-112446 nano
Price before filing: $32.9 (2025-11-13 close, split/dividend-adjusted)
Market cap at flag: $5.0M (2025-11-14) 路 Latest: $14,083 (2026-10-16)
| Window | KALA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -7.9% | +1.3% | -9.2% | 2025-12-15 |
| 90 days | -44.8% | +1.7% | -46.4% | 2026-02-12 |
| 180 days | -90.7% | +11.1% | -101.8% | 2026-05-13 |
| 1 year | pending | pending | until 2026-11-14 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 6 insiders sold $1.3M (10 sales)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | BAKER BROS. ADVISORS LP (+3 joint filers) Former 10% owner | Sale | 21,376 | $1.60 | $34K | no | Form 4 |
| 2025-09-30 | BAKER BROS. ADVISORS LP (+3 joint filers) Former 10% owner | Sale | 195,425 | $1.60 | $312K | no | Form 4 |
| 2025-10-01 | BAKER BROS. ADVISORS LP (+3 joint filers) Former 10% owner | Sale | 50,640 | $1.38 | $70K | no | Form 4 |
| 2025-10-01 | BAKER BROS. ADVISORS LP (+3 joint filers) Former 10% owner | Sale | 462,967 | $1.38 | $641K | no | Form 4 |
| 2025-10-22 | Bazemore Todd Director | Sale | 47,768 | $0.83 | $40K | no | Form 4 |
| 2025-10-22 | Brazzell Romulus K SEE REMARKS | Sale | 46,748 | $0.83 | $39K | no | Form 4 |
| 2025-10-22 | Kharabi Darius CHIEF BUSINESS OFFICER | Sale | 20,806 | $0.83 | $17K | no | Form 4 |
| 2025-10-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | 32,230 | $0.83 | $27K | no | Form 4 |
| 2025-10-23 | Iwicki Mark T Director | Sale | 154,894 | $0.81 | $125K | no | Form 4 |
| 2025-10-23 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | 967 | $0.82 | $793 | no | Form 4 |
| 2025-11-14: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-08-16 to 2025-12-14. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.
Status: filed within extension (report filed 2025-11-19) · the SEC treats a report filed within the extension as timely
Why this score: report filed within the extension on 2025-11-19
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.